APOE and amyloidosis: In subjects at risk for AD, defined either by APOE4 carrier status or amyloidosis or positive family history, no conclusive subfield atrophy pattern is established yet (Donix et al., 2010; Dounavi et al., 2020; McKeever et al., 2020; Nadal et al., 2020).